[Control of the myocardial pump function during cytostatic treatment with anthracycline].
Hesse
B
B
Afdeling for klinisk fysiologi og nuklearmedicin, Rigshospitalet, København.
Mouridsen
H T
HT
Schaadt
B K
BK
Meyer
C
C
D018943:Anthracyclines / Q000009:adverse effects / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009202:Cardiomyopathies / Q000139:chemically induced; D006321:Heart / Q000187:drug effects*; D006801:Humans
D018943:Anthracyclines; D000970:Antineoplastic Agents
Kontrol af hjertets pumpefunktion under cytostatisk behandling med antracykliner.